Stemtech Correlations
| STEK Stock | USD 0 0.0002 14.29% |
The current 90-days correlation between Stemtech and Xebra Brands is -0.19 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Stemtech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Stemtech moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Stemtech Correlation With Market
Modest diversification
The correlation between Stemtech and DJI is 0.27 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Stemtech and DJI in the same portfolio, assuming nothing else is changed.
Stemtech |
The ability to find closely correlated positions to Stemtech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Stemtech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Stemtech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Stemtech to buy it.
Moving together with Stemtech OTC Stock
Moving against Stemtech OTC Stock
| 0.84 | HLNCF | Haleon plc | PairCorr |
| 0.75 | HLN | Haleon plc Aggressive Push | PairCorr |
| 0.74 | TEVA | Teva Pharma Industries Aggressive Push | PairCorr |
| 0.6 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.44 | PNGM | Er Therapeutics | PairCorr |
| 0.84 | APGE | Apogee Therapeutics, | PairCorr |
| 0.7 | CHACR | Crane Harbor Acquisition | PairCorr |
| 0.69 | GM | General Motors | PairCorr |
| 0.64 | AKAM | Akamai Technologies | PairCorr |
| 0.6 | SMGKF | Smiths Group plc | PairCorr |
| 0.6 | BAC | Bank of America | PairCorr |
| 0.59 | 68233JBP8 | US68233JBP84 | PairCorr |
| 0.58 | HL | Hecla Mining Aggressive Push | PairCorr |
| 0.57 | HE | Hawaiian Electric Sell-off Trend | PairCorr |
| 0.49 | IDN | Intellicheck Mobilisa | PairCorr |
| 0.45 | DDS | Dillards, | PairCorr |
| 0.34 | ALVLF | Big Ridge Gold | PairCorr |
| 0.84 | STAG | STAG Industrial | PairCorr |
| 0.79 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.74 | EGP | EastGroup Properties | PairCorr |
| 0.67 | RLMD | Relmada Therapeutics | PairCorr |
| 0.6 | PII | Polaris Industries | PairCorr |
| 0.53 | NOEM | CO2 Energy Transition | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Stemtech OTC Stock performing well and Stemtech OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Stemtech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GRCU | 46.38 | 19.48 | 0.29 | 3.25 | 19.72 | 100.00 | 1,050 | |||
| VRTHF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| XBRAF | 18.36 | 6.42 | 0.00 | (1.67) | 0.00 | 69.23 | 215.18 | |||
| GRPS | 9.19 | 2.11 | 0.06 | (0.29) | 10.01 | 33.33 | 83.33 | |||
| GEATF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ERBB | 14.64 | 2.64 | 0.08 | 0.77 | 13.86 | 50.00 | 83.33 | |||
| NRXCF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TRLFF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| STSN | 6.40 | (0.38) | 0.00 | (0.08) | 0.00 | 26.67 | 63.33 | |||
| DYNT | 6.14 | (0.11) | 0.00 | 0.13 | 0.00 | 22.11 | 51.28 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Stemtech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Stemtech Corporate Management
Elected by the shareholders, the Stemtech's board of directors comprises two types of representatives: Stemtech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Stemtech. The board's role is to monitor Stemtech's management team and ensure that shareholders' interests are well served. Stemtech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Stemtech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charles Arnold | CEO Director | Profile | |
| James Cardwell | Chief Officer | Profile | |
| Alejandro Carrillo | Managing Markets | Profile | |
| John Meyer | COO Pres | Profile |